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Medical end-of-life practices in Swiss
cultural regions: a death certificate study
Samia A. Hurst1 , Ueli Zellweger2, Georg Bosshard3, Matthias Bopp2* and for the Swiss Medical End-of-Life
Decisions Study Group
Abstract
Background: End-of-life decisions remain controversial. Switzerland, with three main languages shared with surrounding
countries and legal suicide assistance, allows exploration of the effects of cultural differences on end-of-life practices
within the same legal framework.
Methods: We conducted a death certificate study on a nationwide continuous random sample of Swiss residents. Using
an internationally standardized tool, we sent 4998, 2965, and 1000 anonymous questionnaires to certifying physicians in
the German-, French-, and Italian-speaking regions.
Results: The response rates were 63.5%, 51.9%, and 61.7% in the German-, French-, and Italian-speaking
regions, respectively. Non-sudden, expected deaths were preceded by medical end-of-life decisions (MELDs)
more frequently in the German- than in the French- or Italian-speaking region (82.3% vs. 75.0% and 74.0%,
respectively), mainly due to forgoing life-prolonging treatment (70.0%, 59.8%, 57.4%). Prevalence of assisted
suicide was similar in the German- and French-speaking regions (1.6%, 1.2%), with no cases reported in the
Italian-speaking region. Patient involvement was smaller in the Italian- than in the French- and German-speaking
regions (16.0%, 31.2%, 35.6%). Continuous deep sedation was more frequent in the Italian- than in the French- and
German-speaking regions (34.4%, 26.9%, 24.5%), and was combined with MELDs in most cases.
Conclusion: We found differences in MELD prevalence similar to those found between European countries. On an
international level, MELDs are comparably frequent in all regions of Switzerland, in line with the greater role given to
patient autonomy. Our findings show how cultural contexts and legislation can interact in shaping the prevalence of
MELDs.
Background
In many countries worldwide, there is persistent contro-
versy surrounding end-of-life decisions, particularly in rela-
tion to assisted suicide and euthanasia. Debates regarding
the legal status of such decisions assume that legislative dif-
ferences [1] and care settings [2, 3] largely determine inter-
national variation in prevalence. Countries where these
decisions are legal and where several cultures co-exist, such
as Switzerland, Belgium, the US, and more recently Canada,
thus present an important opportunity to explore the role
of legal and cultural frameworks for variations of end-of-
life decisions.
Switzerland allows suicide assistance if it is offered
without selfish motive and even when it is practiced by
non-physicians [4], without recognizing an entitlement
to such assistance [5]. In contrast to the Netherlands,
Belgium, and Luxemburg, but similarly to the US states
allowing suicide assistance, euthanasia is not legal [6–8].
“Suicide tourism” toward Switzerland has influenced
end-of-life debates in countries such as Germany, the
UK, the US, and Canada, from which many assisted sui-
cide candidates originate [9].
Switzerland has four official languages, German, French,
Italian, and Romansh, within defined geographical areas.
The language regions share many cultural features with the
respective neighboring countries, offering an opportunity to
explore the effects of cultural differences on end-of-life
practices within the same legal context [10]. Reliable
population-level data on this field has only been collected
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once in Switzerland in 2001, within the EURELD study
[11]. However, the Swiss sample was limited to the
German-speaking region. Other studies suggest that French
physicians’ support for legalizing euthanasia could be
greater [12], and German physicians’ lesser [13], than their
Swiss counterparts. The ETHICUS study showed an in-
crease in frequency in withdrawal of life-sustaining treat-
ment from South to North Europe [14]. In the EURELD
study, however, Sweden and Denmark showed lower preva-
lence than Belgium and the Netherlands, and much lower
prevalence than (German-speaking) Switzerland [15]. Fur-
ther, data from Belgium suggests that cultural differences
between regions affect euthanasia practices within a coun-
try [2]. In Switzerland, substantial variations were described
in physicians’ attitudes between language regions, the most
striking being a reluctance of Italian-speaking doctors
against any kind of end-of-life decisions – in close similarity
to Italy [16].
In 2013, we performed a follow-up study of the Swiss
part of the EURELD study using the same methodology
and largely the same questionnaire [11], but including
the French- and Italian-speaking regions. Comparative
data related to the German-speaking region of
Switzerland in 2001 and 2013 have been published re-
cently [17, 18]. This paper presents cross-sectional data
of the different language regions of Switzerland on med-
ical end-of-life decisions (MELDs).
Methods
Participants
Study methods have been described in more detail else-
where [17, 18]. A continuous random sample of death
certificates of residents aged 1 year or older was selected
on a weekly basis by the Swiss Federal Statistical Office.
We differentiated between German- (71.6% of total
population), French- (23.6%), and Italian-speaking (4.4%)
areas. Since Romansh, the fourth national language, is
only spoken by less than 1% of the national population
and its geographical area is not contiguous, it was
included into the German-speaking region. Taking into
account the smaller population size, the French- and
Italian-speaking regions were oversampled. The sample
size was chosen in order to obtain reliable data from all
three language regions while limiting the risk that some
physicians in the smaller language regions received too
many questionnaires. In total, 21.3%, 41.1%, and 62.9%
of registered deaths were respectively sampled among
residents of the German-, French-, and Italian-speaking
regions of Switzerland, and certifying physicians were
invited to participate. Between August 1, 2013, and
January 31, 2014, we sent 4998, 2965, and 1000 ques-
tionnaires in weekly batches to the three respective lan-
guage regions. The last completed questionnaire arrived
on June 11, 2014.
Survey tool
If death was not sudden and unexpected, the case was
considered eligible for questions regarding end-of-life
decisions. In such cases, physicians were asked whether
they had (1) withheld or withdrawn a probably life-
prolonging medical treatment taking into account or ex-
plicitly intending to hasten the patient’s death; (2) inten-
sified the alleviation of pain and/or symptoms with
drugs taking into account or partly intending to hasten
the patient’s death; or (3) prescribed or administered a
drug with the explicit intention of ending the patient’s
life (physician-assisted death). For this study, we catego-
rized cases as a physician-assisted death when a positive
response was given to question (3), irrespective of an-
swers to questions (1) and (2). Positive answers to ques-
tion (3) were categorized as follows:
(3a) “assisted suicide”, if patients self-administered the
drug to end their life;
(3b) “euthanasia”, if somebody else administered the
drug and the question regarding explicit request of the
patient was answered affirmatively;
(3c) “ending of life without the patient’s explicit re-
quest”, if the question regarding explicit request of the
patient was not answered affirmatively.
To evaluate continuous deep sedation, physicians were
asked if the patient received medicines to maintain them
in a continuous deep sedation or coma until death.
The survey tool was translated into French and Italian,
back translated for quality control, and checked by bilin-
gual individuals. The final questionnaire (four pages) is
available upon request.
Human participant protection
To guarantee anonymity, physicians were requested to re-
turn questionnaires to the Swiss Academy of Medical Sci-
ences. Questionnaires were only forwarded to the
investigators at the Epidemiology, Biostatistics, and Preven-
tion Institute of the University of Zurich (then Institute of
Social and Preventive Medicine) after confirmation that the
code key had been deleted for this case. Questionnaire re-
turn was considered to imply consent to participate. The
study was declared exempt from ethics review by the Zurich
Cantonal Ethics Board (KEK-StV-Nr. 23/13).
Data analysis
Questionnaires were scanned and all data were
weighted to adjust for region-, age-, and sex-specific
differences in response rates. Weighted percentages
and 95% confidence intervals for the comparison of
the three language regions were calculated using
STATA 13.1 survey tables for weighted data (Stata-
Corp LP, College Station, TX, US).
Hurst et al. BMC Medicine  (2018) 16:54 Page 2 of 8
Results
Sample
Of 8963 mailed questionnaires, 3173 (63.5%), 1538 (51.9%),
and 617 (61.7%) were returned from the German-,
French-, and Italian-speaking regions of Switzerland,
respectively, which is comparable to other research
using this method [6].
Medical end-of-life decisions (MELDs)
Non-sudden, expected deaths were preceded by at least
one MELD in a majority of cases, more frequently
(82.3%) in the German- than in the French- (75%) or
Italian-speaking (74%) regions (Table 1). Focusing on
the most explicit practice, forgoing life-prolonging treat-
ment was the most frequent MELD in the German-
speaking region and intensified alleviation of symptoms
the most frequent in the French-speaking region (49.3% of
non-sudden expected deaths and 39.8%, respectively), with
both being similarly frequent in the Italian-speaking
region (34.8% and 37.4%, respectively). Assisted suicide
was reported in 1.6% and 1.2% of non-sudden expected
deaths in the German- and French-speaking regions, with
no cases reported in the Italian-speaking region in our
sample.
MELDs were combined in approximately half of the
cases (Table 2). When all cases including a decision to
forgo life-prolonging treatment were considered, the
intention to shorten life was more frequent than only
taking this into account in the German-speaking region
(44.2% vs. 25.8%), while there were no statistically sig-
nificant differences in the other two regions. Intensified
alleviation of symptoms was similarly prevalent in all
language regions. There was no intention to shorten life
in most cases of alleviation of pain and symptoms; how-
ever, in a minority of cases, shortening of life was partly
intended (more often in the German- and Italian- than
in the French-speaking region).
Continuous deep sedation (CDS)
Death was preceded by medication to bring about CDS
in many non-sudden, expected deaths (Table 3). This was
more frequent in the Italian-speaking region than in the
German- and French-speaking regions (34.4% vs. 24.4%
and 26.9%). CDS were combined with MELDs in most
cases. Deaths preceded by CDS without a MELD were
slightly, but statistically significantly more frequent in the
Italian- than in the German-speaking region (with inter-
mediate prevalence in the French-speaking region).
Table 1 Prevalence of medical end-of-life practicesa in Switzerland 2013, by language region
Regions German-speaking French-speaking Italian-speaking
Number of non-sudden expected deaths
(eligible for end-of-life decision)
N = 2256 N = 992 N = 430
%b 95% CI %b 95% CI %b 95% CI
No end-of-life practice 17.7% (16.2–19.3) 25.0% (22.4–27.9) 26.0% (22.0–30.3)
Forgoing life-prolonging treatment 49.4% (47.3–51.4) 31.6% (28.8–34.6) 34.8% (30.4–39.5)
- taking into account hastening of deathc 6.4% (5.4–7.5) 5.2% (4.0–6.7) 4.7% (3.0–7.1)
- intending hastening of deathd 43.0% (40.9–45.0) 26.5% (23.8–29.3) 30.1% (26–34.7)
Intensified alleviation of pain/symptoms 29.8% (28.0–31.7) 39.8% (36.8–42.9) 37.4% (33.0–42.1)
- taking into account hastening of deathe 26.9% (25.1–28.8) 36.6% (33.7–39.7) 33.8% (29.5–38.4)
- partly intending hastening of deathf 2.9% (2.3–3.7) 3.2% (2.3–4.5) 3.6% (2.2–5.8)
Physician-assisted death 3.1% (2.5–3.9) 3.5% (2.5–4.8) 1.8% (0.9–3.6)
- Assisted suicideg 1.6% (1.1–2.2) 1.2% (0.6–2.1) –
- Euthanasiah 0.5% (0.3–0.9) 0.5% (0.2–1.2) 0.5% (0.1–1.8)
- Ending of life without the patient’s explicit requesti 1.1% (0.8–1.6) 1.9% (1.2–2.9) 1.4% (0.6–3.0)
aIf several practices were combined, the most explicit action was decisive; e.g., combinations of physician-assisted death with forgoing life-prolonging treatments
or intensified alleviation of pain and symptoms were categorized under physician-assisted death
b100% = all non-sudden expected deaths; percentages weighted to region-sex-age-specific response rates
cAffirmative answer to the question, “Did you or another physician withhold or withdraw a medical treatment while taking into account the possible hastening
of death?”
dAffirmative answer to the question, “Did you or another physician withhold or withdraw a medical treatment with the intention to hasten death?”
eAffirmative answer to the question, “Did you or another physician intensify the alleviation of pain and/or symptoms while taking into account the possible
hastening of death?”
fAffirmative answer to the question, “Did you or another physician intensify the alleviation of pain and/or symptoms partly with the intention to hasten death?”
gAffirmative answer to the question, “Was death the consequence of the use of a drug that was prescribed or supplied by you or another physician with the
explicit intention of enabling the patient to end his or her life?”
hAffirmative answer to the question, “Was death the consequence of the use of a drug that was prescribed or supplied by you or another physician with the
explicit intention of hastening the patient’s death?” AND affirmative answer to the question: “Was this decision made at the explicit request of the patient?”
iAffirmative answer to the question, “Was death the consequence of the use of a drug that was prescribed or supplied by you or another physician with the
explicit intention of hastening the patient’s death?” AND no affirmative answer to the question: “Was this decision made at the explicit request of the patient?”
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Place of death
As outlined in Table 4, non-sudden expected deaths were
more likely to occur without MELDs at home (25.8%)
than in hospitals (15.7%) or nursing homes (17.6%) in the
German-speaking region (Table 4). Forgoing life-
prolonging treatment was less frequent at home than in
hospitals or long-term care homes in the German-
speaking region, and less frequent at home than in hospi-
tals in the French-speaking region. Intensified alleviation
of symptoms showed similar prevalence in all places of
death in the French- and Italian-speaking regions, but was
more frequent in hospitals (68.8%) and less frequent for
home (53.1%) deaths than in long-term care homes (62.7%)
in the German-speaking region. Assisted suicide was
more frequent at home in the German- (4.2%) and
French-speaking (9%) regions, and did not occur in our
sample in the Italian-speaking region.
Shared decision-making
Most MELDs were discussed with the patient or rela-
tives, or based on previously known patient wishes
(Table 5), with only a minority being discussed with the
patient at the time of the decision. Patient involvement
was less frequent in the Italian-speaking region (16%), as
compared to the French- (31.2%) and German-speaking
(35.6%) regions. Even when patients were fully capable
of decision-making, up to 40% of MELDs occurred with-
out their involvement, and approximately 12% occurred
even without involving their relatives and without know-
ledge of previously expressed patient wishes.
Table 2 Forgoing life-prolonging treatment and intensified alleviation of pain and symptoms, Switzerland 2013, by language region
Regions German-speaking French-speaking Italian-speaking
Number of non-sudden expected deaths
(eligible for end-of-life decision)
N = 2256 N = 992 N = 430
%a 95% CI %a 95% CI %a 95% CI
Forgoing life-prolonging treatment
Total 70.0% (68.1–71.9) 59.8% (56.7–62.8) 57.4% (52.7–62.0)
- taking into account hastening of death 25.8% (24.0–27.6) 32.1% (29.3–35.1) 25.7% (21.8–30.1)
- intending hastening of death 44.2% (42.2–46.3) 27.7% (25.0–30.6) 31.7% (27.5–36.3)
- not combined with other medical end-of-life practice (1) 17.3% (15.8–18.9) 12.5% (10.6–14.7) 10.2% (7.7–13.5)
- combined with intensified alleviation of pain/symptoms only 51.2% (49.1–53.2) 45.0% (41.9–48.1) 45.4% (40.7–50.1)
- ditto, only intended forgoing treatment (2) 32.0% (30.1–34.0) 19.2% (16.8–21.7) 24.6% (20.7–28.9)
- combined with physician-assisted death 1.5% (0.1–2.1) 2.3% (1.5–3.5) 1.8% (0.9–3.6)
Intensified alleviation of pain/symptoms
Total 63.4% (61.4–65.3) 61.4% (58.3–64.4) 63.8% (59.1–68.2)
- taking into account hastening of death 51.7% (49.7–53.8) 53.8% (50.7–56.9) 48.8% (44.1–53.5)
- partly intending hastening of death 11.6% (10.4–13.0) 7.6% (6.1–9.4) 15.0% (11.9–18.8)
- not combined with other medical end-of-life practice (3) 10.7% (9.5–12.0) 14.0% (12.0–16.4) 16.6% (13.4–20.5)
- combined with forgoing life-prolonging treatment only 51.2% (49.1–53.2) 45.0% (41.9–48.1) 45.4% (40.7–50.1)
- ditto, only non-intended forgoing treatment (4) 19.1% (17.6–20.8) 25.8% (23.2–28.7) 20.8% (17.2–24.9)
- combined with physician-assisted death 1.5% (0.1–2.1) 24.0% (1.6–3.6) 1.8% (0.9–3.6)
a100% = all non-sudden expected deaths; percentages weighted to region-sex-age-specific response rates
Data in this table include cases in which more than one end-of-life decision were taken
Forgoing life-prolonging treatment as most explicit end-of-life decision (cf. Table 1): (1) + (2)
Intensified alleviation of pain/symptoms as most explicit end-of-life decision (cf. Table 1): (3) + (4)
Table 3 Continuous deep sedation in Switzerland 2013, by language region
Regions German-speaking French-speaking Italian-speaking
Non-sudden expected deaths N = 2256 N = 992 N = 430
%a 95% CI %a 95% CI %a 95% CI
Continuous deep sedation until death (CDS) 24.5% (22.3–26.3) 26.9% (24.2–29.7) 34.4% (30.1–39.0)
- CDS without end-of-life decision 1.6% (1.2–2.2) 3.2% (2.2–4.5) 5.1% (3.4–7.6)
- CDS combined with end-of-life decision 22.8% (21.1–25.6) 23.7% (21.2–26.5) 29.3% (25.2–33.8)
a100% = all non-sudden expected deaths; percentages weighted to region-sex-age-specific response rates
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Table 4 Prevalence of medical end-of-life practices, Switzerland 2013, by language region and place of death
Regions German-speaking French-speaking Italian-speaking
Number of non-sudden expected deaths
(eligible for end-of-life decision)
N = 2256 N = 992 N = 430
%a 95% CI %a 95% CI %a 95% CI
At home N = 265 N = 96 N = 67
11.6% (10.4–13) 9.5% (7.9–11.5) 15.6% (12.4–19.3)
No end-of-life practice 25.8 (20.9–31.4) 24.6 (17.0–34.2) 31.1 (21.1–43.2)
Forgoing treatment total 60.3 (54.2–66.0) 47.0 (37.2–57.1) 45.8 (34.2–57.8)
Alleviation of pain & symptoms total 53.1 (47.1–59.1) 60.2 (50.0–69.6) 63.1 (51.0–73.8)
vPhysician-assisted death total 5.7 (3.5–9.2) 15.4 (9.3–24.4) 1.6 (0.2–10.5)
- Assisted suicide 4.2 (2.3–7.5) 9.0 (4.6–17.0) –
In long-term care homes N = 982 N = 371 N = 186
44.3% (42.3–46.4) 38.6% (35.6–41.7) 43.1% (38.5–47.8)
No end-of-life practice 17.6 (15.3–20.1) 23.9 (19.8–28.5) 27.1 (21.2–34.0)
Forgoing treatment total 71.5 (68.6–74.3) 59.1 (53.9–64.0) 54.8 (47.6–61.8)
Alleviation of pain and symptoms total 62.7 (59.6–65.7) 63.2 (58.2–68.0) 63.1 (55.9–69.8)
Physician-assisted death total 1.2 (0.7–2.2) 3.0 (1.7–5.4) 3.1 (1.4–6.8)
- Assisted suicide 0.1 (0.0–0.8) 0.3 (0.0–2.0) –
In hospital N = 973 N = 522 N = 174
42.5% (40.5–44.6) 51.5% (48.4–54.7) 40.6% (36.1–45.4)
No end-of-life practice 15.7 (13.5–18.1) 26.0 (22.4–30.0) 22.7 (17.0–29.5)
Forgoing treatment total 73.6 (70.4–75.9) 62.6 (58.4–66.7) 64.5 (57.1–71.3)
Alleviation of pain and symptoms total 68.8 (65.8–71.6) 60.2 (55.9–64.4) 65.9 (58.6–72.6)
Physician-assisted death total 2.0 (1.3–3.1) 1.7 (0.9–3.2) 0.5 (0.1–3.8)
- Assisted suicide – 0.4 (0.1–1.4) –
a100% = all non-sudden expected deaths; percentages weighted to region-sex-age-specific response rates
Data in this table include cases in which more than one end-of-life decision were taken
Table 5 Discussion of medical end-of-life decisionsa in function of the patient’s decision-making capacity, Switzerland 2013, by
language region
Regions German-speaking French-speaking Italian-speaking
Deaths with end-of-life practice mentioned
(eligible for involvement)
N = 1856 N = 744 N = 318
%b 95% CI %b 95% CI %b 95% CI
Discussed with patient 35.6% (33.4–37.5) 31.2% (27.9–34.6) 16.0% (12.4–20.4)
Patient fully capable 73.3% (69.6–76.6) 71.2% (65.3–76.5) 60.0% (47.2–71.6)
Patient not fully capable 37.1% (32.3–42.3) 30.3% (22.9–38.8) 8.4% (3.8–17.6)
Patient not capable at all 9.7% (7.6–12.2) 5.8% (3.4–9.6) 6.9% (3.6–12.8)
Patient’s capacity unknown 3.4% (1.7–6.7) – –
Discussed with patient and/or relatives and/or patient ever expressed wish 76.5% (74.5–78.4) 73.8% (70.5–76.9) 69.0% (63.7–73.8)
Patient fully capable 87.8% (85.0–90.2) 88.5% (84.0–91.9) 87.4% (76.5–93.6)
Patient not fully capable 85.3% (81.2–88.6) 82.9% (75.3–88.5) 75.6% (64.4–84.1)
Patient not capable at all 79.8% (76.5–82.7) 82.2% (76.6–86.6) 82.8% (75.3–88.4)
Patient’s capacity unknown 22.1% (17.2–28.0) 20.4% (14.2–28.4) 13.1% (6.6–24.2)
aCDS is not a MELD and is thus not included in this table
b100% = all deaths with reported end-of-life practice; percentages weighted to region-sex-age-specific response rates
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Discussion
To our best knowledge, this is the first population-level
death-certificate study allowing comparison of real prac-
tice MELDs other than euthanasia between different cul-
tural regions within the same country. Our study shows
that MELDs are more frequent overall in the German-
speaking region, and the prevalence of the MELD
deemed most explicit varies between the three language
regions in Switzerland, supporting the view that cultural
differences subsist under the same legal system [2]. The
view of Switzerland as “Europe in miniature” [16] is at
least partly corroborated by our results. International
comparison nevertheless shows a generally high propor-
tion of MELDs in all regions of Switzerland when com-
pared to countries sharing a language, such as France
[19] or Italy [11], with no data currently available on the
practice of MELD in Germany or Austria. This is in line
with other studies suggesting that Switzerland is among
the European countries where patient autonomy is given
a greater weight in MELDs [20, 21].
Previous studies have shown distinct national cultures
of end-of-life care [22]. Cultural influence on physicians’
views of MELDs within the same country have been re-
ported in a former Swiss survey [16] as well as between
Walloon and Flemish physicians in Belgium [2]. Differ-
ences in patients’ and families’ requests may have even
more impact than physicians’ attitudes [20]. Despite being
limited to a single specialty, reports of practices by a Senti-
nel Network of General Practitioners in the Dutch- and
French-speaking regions of Belgium had also shown that
the prevalence of MELDs was higher in the Dutch- than
in the French-speaking community [23].
Our data suggest greater reluctance in forgoing life-
prolonging treatment in the French- and Italian-
speaking regions than in the German-speaking region,
with partial replacement through either intensified alle-
viation of symptoms or CDS in French- and Italian-
speaking regions. This is consonant with data from
Belgium, showing more negative attitudes towards eu-
thanasia and lower rates of reporting from the French-
as compared to the Dutch-speaking region [2], and
higher prevalence of CDS among French- than among
Dutch-speaking physicians in the Brussels area [24]. In
contrast, variation of intensified alleviation of symptoms
between regions was almost absent in our sample. It has
been proposed that this could be due to a perception
that this constitutes a more direct response to a clinical
situation [20]. There were no significant differences in
the practice of suicide assistance in the German- and
French-speaking regions, yet our sample recorded no
case of suicide assistance in the Italian-speaking re-
gion [25].
International comparisons show a generally high
proportion of MELDs in all regions of Switzerland.
Although these data were collected at different times,
overall prevalence for MELDs was somewhat lower in
France than in the French-speaking region [19] and sub-
stantially lower in Italy than in the Italian-speaking re-
gion of Switzerland [11]. Further, forgoing life-
prolonging treatment was somewhat less frequent, and
intensified alleviation of symptoms somewhat more fre-
quent, in France than in the French-speaking region of
Switzerland [19]. No comparative data are available from
Germany.
Greater reluctance to forgo life-prolonging treatment
may not be due to identical factors in the French- and
Italian-speaking regions. The observed greater preva-
lence of hospital deaths in the French-speaking region
suggests a greater tendency to pursue treatment, a find-
ing consonant with greater appreciation of curative,
technological, and specialist medicine in the French-
speaking than in the Dutch-speaking community in
Belgium [23]. Additionally, it is also consistent with a
health system focus on hospitals rather than nursing
homes in the French-speaking region, and with data
showing structural effects of health systems on place of
death [26]. However, this cannot explain the greater re-
luctance in the Italian-speaking region, where more
deaths occurred at home than in the French-speaking
region.
That most assisted suicide found in our sample took
place at home is consistent with many hospitals’ reluc-
tance to allow suicide assistance, but also with data sug-
gesting that the key reasons for patients to choose their
homes include a concern to avoid loss of control [25].
Patient involvement in decisions was less frequent in
the Italian-speaking region. Although this was mostly
the case for patients deemed “not fully capable”, a simi-
lar trend was shown for fully capable patients and those
allocated to this category represented an implausibly
small proportion when compared to the other two lan-
guage regions. These data suggest that Italian-speaking
doctors may be loath to discuss MELD, possibly because
they have remained ambivalent towards MELDs, as sug-
gested by previous findings comparing attitudes [16].
This is also consistent with international data showing
higher prevalence of treatment preference discussions
with Belgian and Dutch than with Spanish and Italian
patients [27]. We did not find differences in the involve-
ment of patients in the German- and French-speaking
regions. However, a comparison of patient involvement
in the Flemish- and French-speaking regions of Belgium
did not show significant differences in patient involve-
ment either [23].
Although culture is being used as an “umbrella term”
herein, encompassing many different elements, our
findings are compatible with the view that, compared to
the German-speaking region, a more family-oriented
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approach is prevalent in the Italian-speaking region and
a more technology-oriented approach in the French-
speaking region. End-of-life decisions are debated simul-
taneously within countries, within single-language trans-
national regions, and internationally. Although these
differences require qualitative exploration in order to be
better understood, our results may show how national
and language-based discussions can interact.
Our study has several limitations. The optimal phras-
ing of the questionnaire for international comparison
purposes remains controversial [28]; this, however, is un-
likely to affect intra-national comparison. We cannot ex-
clude the possibility of a non-response bias, especially
since responding that death was sudden and unexpected
offered an easy option to skip all potentially sensitive
questions. This would not have affected the intra-
national comparison, were it not for the fact that re-
sponse rates were different in the three language regions.
This effect is not likely to be large; indeed, response
rates in our study were remarkably high, especially given
the fact that our survey had no official monitoring mis-
sion. Even in the French-speaking region, where re-
sponse rates were lowest, they were clearly higher than
in France (40%) [19] and Italy (44%) [11]. We may
nevertheless have underestimated the prevalence of
MELDs. The observation unit was deaths and not physi-
cians; several physicians filled in more than one ques-
tionnaire. Due to the anonymous nature of the survey,
questionnaires stemming from the same physician could
not be identified. Therefore, the results are not necessar-
ily representative for Swiss physicians. Although our
sample size was much larger than other similar studies
[23], small differences in the prevalence of MELDs may
nevertheless have escaped our sample size, especially in
the smaller language regions. More importantly, this
method only allows exploration of what physicians be-
lieve happened. Depending on respondents’ technical
knowledge regarding MELDs, their beliefs may some-
times have been mistaken [29]. Despite this, this kind of
study is still widely accepted as the gold standard for
assessing MELDs on a population level.
Conclusion
Differences within Switzerland partly reflect practices in
countries with the same linguistic tradition, but inter-
national comparisons show a generally high proportion
of MELDs in all areas of the country, in line with the
greater role given to patient autonomy. Our findings
show how cultural contexts and legislation can interact
in shaping the prevalence of MELDs.
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